Status:

WITHDRAWN

The Use of Nutropin Depot in HIV-infected Adult Males

Lead Sponsor:

University of Texas Southwestern Medical Center

Collaborating Sponsors:

Genentech, Inc.

Conditions:

HIV Infection

Eligibility:

MALE

18+ years

Phase:

PHASE2

PHASE3

Brief Summary

This is a pilot study. We will treat 10 HIV-infected adults (1/2 with lipoatrophy) with GH depot for one year. Results will be compared to data from 10 HIV patients (1/2 with lipoatrophy), treated wit...

Detailed Description

Patients will be recruited from the HIV clinics at University of Texas Southwestern Medical School and the Veterans Administration Hospital by direct invitation from Dr. Margolis (adult HIV clinic dir...

Eligibility Criteria

Inclusion

  • adult males ≥ 18 years of age
  • mild to moderate lipoatrophy
  • stable protease inhibitor therapy for at least six months.

Exclusion

  • Con-current supra-infection with acute illness defined by fever or bacterial culture
  • malignancy
  • females
  • diabetes mellitus
  • CNS tumors.

Key Trial Info

Start Date :

February 1 2006

Trial Type :

INTERVENTIONAL

Allocation :

ACTUAL

End Date :

February 1 2006

Estimated Enrollment :

Patients enrolled

Trial Details

Trial ID

NCT00286676

Start Date

February 1 2006

End Date

February 1 2006

Last Update

December 26 2018

Active Locations (3)

Enter a location and click search to find clinical trials sorted by distance.

Page 1 of 1 (3 locations)

1

Aston Ambulatory Care Center

Dallas, Texas, United States, 75390

2

Parkland Health & Hospital System

Dallas, Texas, United States, 75390

3

Veteran's Affairs Medical Center

Dallas, Texas, United States

The Use of Nutropin Depot in HIV-infected Adult Males | DecenTrialz